FDA and pharmaceutical company warns of drug mix-up

The FDA and Baxter International Inc. (a pharmaceutical company) are warning health care providers about mix-ups of two heparin products. These mix-ups recently resulted in the death of three infants. The deaths occurred when a higher dose of Heparin Sodium Injection, at 10,000 units a milliliter, was inadvertently administered instead of a lower dose. Both products are in the same size vial and use different shades of blue as the prominent background color on their label. The similarity between the two bottles makes providers prone to medical malpractice in administering the drug.

For the full article.

Lawyer Monthly - Legal Awards Winner
The National Trial Lawyers
Elder Care Matters Alliance
American Association for Justice
Fellow Litigation Counsel of America
Super Lawyers